Antiretroviral medication compliance in patients with AIDS

AIDS Patient Care and STDs

Volumn 12, Issue 6, 1998, Pages 463-470

  Frick, Pamela A ^a   Gal, Peter ^b   Lane, Timothy W ^c,d   Sewell, Patricia C ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Moses H Cone Hospital   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG USE; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; TREATMENT INDICATION; VIRUS MUTATION; VIRUS RESISTANCE;

EID: 0031859773     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.463     Document Type: Article

References (12)

1. Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med, 92:495-502, 1992.
2. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. AJHP 48:1978-1988, 1991.
3. Rudd P, Lenert L. Pharmacokinetics as an aid to optimizing compliance with medications. Clin Pharmacokinetics, 28:1-6, 1995.
4. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? JAMA 261: 3273-3277, 1989.
5. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 150: 1377-1378, 1990.
6. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in organ transplant recipients. Transplant Proc 21: 833-834, 1989.
7. Geletko SM, Segarra M, Mayer KH, et al. Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. Antimicrob Agents Chemother 40:1338-1341, 1996.
8. Vanhove GF, Schapiro JM, Winters MA, et al. (Letter) Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 276:1954-1955, 1996.
9. Schapiro JM, Winters MA, Vierra M, et al. Causes of long term efficacy and/or drug failure in protease inhibitor monotherapy. Abstract M.O.B. 414. XI International Conference on AIDS, Vancouver, Canada, 1996.
10. Hondir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 124:984-994, 1996.
11. Woodward WC. Should directly observed therapy be considered for treatment of HIV? [Letter]. JAMA 1956:276, 1996.
12. + T-cell counts in HIV-infected patients. Ann Intern Med 124:1039-1050, 1996.